Predictive value of cathepsin-D for cervical lymph node metastasis in head and neck squamous cell carcinoma

Regina F Gandour-Edwards, Bruce Trock, Paul J. Donald

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Background. Prognosis of head and neck squamous cell carcinoma (HNSCC) is strongly associated with cervical lymph node metastasis. Cathepsin-D is a lysosomal protease expressed in all cells. Its role in extracellular matrix degradation is postulated to promote tumor invasion and metastasis. Increased cathepsin-D has been demonstrated in cervical lymph node metastasis in HNSCC. Methods. Formalin fixed tumor biopsy samples from 34 patients with HNSCC of the oral cavity, oropharynx, or hypopharynx were analyzed for the presence of cathepsin-D by immunohistochemistry (1:8000, Calbiochem, Cambridge, MA). Tumors were considered positive if >50% of cells showed strong cytoplasmic staining. Results. All patients had T1 or T2 lesions ranging in size from 1-4 cm and 19 (56%) had cervical metastasis. Eight (24%) were well differentiated and 26 (76%) were moderately or poorly differentiated. Thirteen tumors (38%) had high cathepsin-D expression that was strongly associated with cervical lymph node metastasis (p = 0.008). When adjusted for tumor stage and grade, cathepsin-D positivity was nearly twice as likely to be associated with node metastasis (p = 0.011). Conclusions. We demonstrated cathepsin-D expression in biopsies from a subset of patients with HNSCC and a strong association between this protease and cervical lymph node metastases. Cathepsin-D is a potential independent predictor of cervical lymph node metastasis in HNSCC and merits additional study.

Original languageEnglish (US)
Pages (from-to)718-722
Number of pages5
JournalHead and Neck
Volume21
Issue number8
DOIs
StatePublished - Dec 1999

Fingerprint

Cathepsin D
Lymph Nodes
Neoplasm Metastasis
Neoplasms
Peptide Hydrolases
Biopsy
Hypopharynx
Oropharynx
Carcinoma, squamous cell of head and neck
Formaldehyde
Extracellular Matrix
Mouth
Immunohistochemistry
Staining and Labeling

Keywords

  • Cathepsin-D
  • Cervical lymph node metastasis
  • Head and neck cancer
  • Predictive markers
  • Squamous cell carcinoma

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Predictive value of cathepsin-D for cervical lymph node metastasis in head and neck squamous cell carcinoma. / Gandour-Edwards, Regina F; Trock, Bruce; Donald, Paul J.

In: Head and Neck, Vol. 21, No. 8, 12.1999, p. 718-722.

Research output: Contribution to journalArticle

@article{17b653fd4bd8468b986569e94642a726,
title = "Predictive value of cathepsin-D for cervical lymph node metastasis in head and neck squamous cell carcinoma",
abstract = "Background. Prognosis of head and neck squamous cell carcinoma (HNSCC) is strongly associated with cervical lymph node metastasis. Cathepsin-D is a lysosomal protease expressed in all cells. Its role in extracellular matrix degradation is postulated to promote tumor invasion and metastasis. Increased cathepsin-D has been demonstrated in cervical lymph node metastasis in HNSCC. Methods. Formalin fixed tumor biopsy samples from 34 patients with HNSCC of the oral cavity, oropharynx, or hypopharynx were analyzed for the presence of cathepsin-D by immunohistochemistry (1:8000, Calbiochem, Cambridge, MA). Tumors were considered positive if >50{\%} of cells showed strong cytoplasmic staining. Results. All patients had T1 or T2 lesions ranging in size from 1-4 cm and 19 (56{\%}) had cervical metastasis. Eight (24{\%}) were well differentiated and 26 (76{\%}) were moderately or poorly differentiated. Thirteen tumors (38{\%}) had high cathepsin-D expression that was strongly associated with cervical lymph node metastasis (p = 0.008). When adjusted for tumor stage and grade, cathepsin-D positivity was nearly twice as likely to be associated with node metastasis (p = 0.011). Conclusions. We demonstrated cathepsin-D expression in biopsies from a subset of patients with HNSCC and a strong association between this protease and cervical lymph node metastases. Cathepsin-D is a potential independent predictor of cervical lymph node metastasis in HNSCC and merits additional study.",
keywords = "Cathepsin-D, Cervical lymph node metastasis, Head and neck cancer, Predictive markers, Squamous cell carcinoma",
author = "Gandour-Edwards, {Regina F} and Bruce Trock and Donald, {Paul J.}",
year = "1999",
month = "12",
doi = "10.1002/(SICI)1097-0347(199912)21:8<718::AID-HED6>3.0.CO;2-W",
language = "English (US)",
volume = "21",
pages = "718--722",
journal = "Head and Neck Surgery",
issn = "0148-6403",
publisher = "Wiley-Liss Inc.",
number = "8",

}

TY - JOUR

T1 - Predictive value of cathepsin-D for cervical lymph node metastasis in head and neck squamous cell carcinoma

AU - Gandour-Edwards, Regina F

AU - Trock, Bruce

AU - Donald, Paul J.

PY - 1999/12

Y1 - 1999/12

N2 - Background. Prognosis of head and neck squamous cell carcinoma (HNSCC) is strongly associated with cervical lymph node metastasis. Cathepsin-D is a lysosomal protease expressed in all cells. Its role in extracellular matrix degradation is postulated to promote tumor invasion and metastasis. Increased cathepsin-D has been demonstrated in cervical lymph node metastasis in HNSCC. Methods. Formalin fixed tumor biopsy samples from 34 patients with HNSCC of the oral cavity, oropharynx, or hypopharynx were analyzed for the presence of cathepsin-D by immunohistochemistry (1:8000, Calbiochem, Cambridge, MA). Tumors were considered positive if >50% of cells showed strong cytoplasmic staining. Results. All patients had T1 or T2 lesions ranging in size from 1-4 cm and 19 (56%) had cervical metastasis. Eight (24%) were well differentiated and 26 (76%) were moderately or poorly differentiated. Thirteen tumors (38%) had high cathepsin-D expression that was strongly associated with cervical lymph node metastasis (p = 0.008). When adjusted for tumor stage and grade, cathepsin-D positivity was nearly twice as likely to be associated with node metastasis (p = 0.011). Conclusions. We demonstrated cathepsin-D expression in biopsies from a subset of patients with HNSCC and a strong association between this protease and cervical lymph node metastases. Cathepsin-D is a potential independent predictor of cervical lymph node metastasis in HNSCC and merits additional study.

AB - Background. Prognosis of head and neck squamous cell carcinoma (HNSCC) is strongly associated with cervical lymph node metastasis. Cathepsin-D is a lysosomal protease expressed in all cells. Its role in extracellular matrix degradation is postulated to promote tumor invasion and metastasis. Increased cathepsin-D has been demonstrated in cervical lymph node metastasis in HNSCC. Methods. Formalin fixed tumor biopsy samples from 34 patients with HNSCC of the oral cavity, oropharynx, or hypopharynx were analyzed for the presence of cathepsin-D by immunohistochemistry (1:8000, Calbiochem, Cambridge, MA). Tumors were considered positive if >50% of cells showed strong cytoplasmic staining. Results. All patients had T1 or T2 lesions ranging in size from 1-4 cm and 19 (56%) had cervical metastasis. Eight (24%) were well differentiated and 26 (76%) were moderately or poorly differentiated. Thirteen tumors (38%) had high cathepsin-D expression that was strongly associated with cervical lymph node metastasis (p = 0.008). When adjusted for tumor stage and grade, cathepsin-D positivity was nearly twice as likely to be associated with node metastasis (p = 0.011). Conclusions. We demonstrated cathepsin-D expression in biopsies from a subset of patients with HNSCC and a strong association between this protease and cervical lymph node metastases. Cathepsin-D is a potential independent predictor of cervical lymph node metastasis in HNSCC and merits additional study.

KW - Cathepsin-D

KW - Cervical lymph node metastasis

KW - Head and neck cancer

KW - Predictive markers

KW - Squamous cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=0032741649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032741649&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0347(199912)21:8<718::AID-HED6>3.0.CO;2-W

DO - 10.1002/(SICI)1097-0347(199912)21:8<718::AID-HED6>3.0.CO;2-W

M3 - Article

VL - 21

SP - 718

EP - 722

JO - Head and Neck Surgery

JF - Head and Neck Surgery

SN - 0148-6403

IS - 8

ER -